MORGAN STANLEY - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$2,206,073
-50.2%
404,783
-38.7%
0.00%
Q2 2023$4,432,048
-29.7%
660,513
-7.5%
0.00%
-100.0%
Q1 2023$6,303,931
-41.4%
713,922
-49.3%
0.00%0.0%
Q4 2022$10,754,751
+47.9%
1,407,690
+37.8%
0.00%0.0%
Q3 2022$7,274,000
-21.6%
1,021,461
-11.0%
0.00%0.0%
Q2 2022$9,282,000
+31.8%
1,147,366
+126.2%
0.00%0.0%
Q1 2022$7,040,000
-35.9%
507,254
+29.5%
0.00%0.0%
Q4 2021$10,989,000
-30.4%
391,679
-15.7%
0.00%
-50.0%
Q3 2021$15,794,000
-21.7%
464,629
-5.9%
0.00%
-33.3%
Q2 2021$20,179,000
-16.0%
493,823
-17.3%
0.00%
-25.0%
Q1 2021$24,027,000
-4.6%
596,792
+40.1%
0.00%0.0%
Q4 2020$25,183,000
+74.2%
425,910
+43.2%
0.00%
+33.3%
Q3 2020$14,460,000
+40.0%
297,346
+39.2%
0.00%
+50.0%
Q2 2020$10,330,000
+65.7%
213,542
-4.8%
0.00%0.0%
Q1 2020$6,233,000
-1.9%
224,382
+5.6%
0.00%
+100.0%
Q4 2019$6,355,000
+20.2%
212,389
+24.1%
0.00%0.0%
Q3 2019$5,289,000
-27.5%
171,173
+13.3%
0.00%
-50.0%
Q2 2019$7,297,000151,0870.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders